Pure Extracts Receives Initial Purchase Order from New Brunswick
Pure Extracts Receives Initial Purchase Order from New Brunswick
VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) ("Pure Extracts" or the "Company"), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has received an initial purchase order (PO) for its cannabis vape cartridges from Cannabis NB, the sole retailer of nonmedical cannabis in the province of New Brunswick.
温哥華，不列顛哥倫比亞省，2022年3月10日(環球通訊社)純萃取技術公司(CSE：PRXTF)(場外交易代碼：PRXTF)(XFRA：A2QJAJ)(“純提取物”或“公司”)，一家專注於大麻、大麻、功能性蘑菇和迅速崛起的迷幻行業的植物性提取物公司，高興地宣佈，其全資子公司Pure Extracts Manufacturing Corp.收到了大麻蒸發盒的初步訂單(PO)，該公司是印度非醫用大麻的唯一零售商。
The Purchase Order (PO) is for 3 SKUs of 1.0 gram Pure Pulls branded vape cartridges filled with a selection of some of the Company's 30+ proprietary cannabis full-spectrum oil (FSO) and CBD formulations.
採購訂單(PO)是3個1.0克的SKU Pure Pure品牌蒸汽盒，裝滿了該公司30多種專有大麻全光譜油(FSO)和CBD配方中的一部分。
Pure Extracts CEO, Ben Nikolaevsky, remarked, "We are pleased to be expanding our sales and brand awareness outside of British Columbia, Alberta, Saskatchewan and Ontario into Eastern Canada. The New Brunswick PO reflects both the high-quality of our products and the consumer demand for legacy brands."
Pure Extracts首席執行官本·尼古拉夫斯基説：“我們很高興能夠將我們的銷售和品牌知名度從不列顛哥倫比亞省、艾伯塔省、薩斯喀徹温省和安大略省擴展到加拿大東部。新不倫瑞克PO既反映了我們產品的高質量，也反映了消費者對傳統品牌的需求。”
ON BEHALF OF THE BOARD
"Ben Nikolaevsky"
Ben Nikolaevsky
CEO and Director
About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company's stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
我代表董事會
“本·尼古拉耶夫斯基”(Ben Nikolaevsky)
本·尼古拉耶夫斯基
首席執行官兼董事
關於純萃取物(CSE：Pull)(場外交易：PRXTF)(XFRA：A2QJAJ)
Pure Extracts Technology Corp.擁有一個全新的、最先進的加工設施，位於世界著名的不列顛哥倫比亞省惠斯勒以北僅20分鐘車程。這個定製設施是按照歐盟GMP標準建造的，旨在將產品和配方(包括目前在加拿大受到限制的產品和配方)出口到合法可獲得的歐洲司法管轄區。根據2020年9月25日的大麻法案和2021年7月19日的銷售修正案，純萃取物獲得了加拿大衞生部頒發的標準加工許可證。該公司的股票於2020年11月5日在加拿大證券交易所(CSE)開始交易。
Find out more at
瞭解更多信息
Or contact:
Pure Extracts Investor Relations
Tel: +1 604 493 2052
info@pureextractscorp.com
This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts', are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk Factors" in the Company's Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.
或聯繫方式：
純提取投資者關係
電話：+16044932052
郵箱：info@pureExtract tcotp.com
本新聞稿包含與Pure Extract公司未來運營有關的前瞻性陳述，其他陳述不是歷史事實。前瞻性陳述通常由諸如“將”、“可能”、“應該”、“預期”、“期望”和類似的表達方式來識別。本新聞稿中除歷史事實陳述外的所有陳述，包括但不限於有關Pure Extract的未來計劃和目標的陳述，均為前瞻性陳述，涉及風險和不確定因素。許多因素可能導致實際事件、業績或結果與前瞻性陳述中預測的大不相同。儘管我們認為這些陳述背後的假設是合理的，但它們可能被證明是不正確的，我們不能保證實際結果與這些前瞻性陳述一致。鑑於這些風險、不確定性和假設，投資者不應過度依賴這些前瞻性陳述。無論實際結果、業績或成就是否符合公司的預期和預測，都會受到許多已知和未知的風險、不確定性、假設和其他因素的影響，包括那些在公司年度信息表格中的“風險因素”中列出的因素。除非適用的證券法要求，否則公司不承諾更新任何前瞻性信息。
This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. The financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from any agreements recently entered into by the Company and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.
本新聞稿包含有關供應協議的潛在銷售收入的信息，根據適用的證券法，這可能被視為財務前景的披露。此類信息受上段所述的相同假設、風險因素、限制和限制。具體地説，可能來自供應合同的估計銷售收入是根據當前的批發價計算的，並假設該公司將能夠為其產品找到買家。本新聞稿中包含的財務展望是由管理層在本新聞稿發佈之日作出的，目的是讓讀者瞭解潛在的收入，這些收入可能來自公司最近簽訂的任何協議，而不是對盈利能力的估計或任何其他財務表現的衡量標準。提醒讀者，本文件中包含的財務展望不應用於本文披露以外的其他目的。
The CSE has neither approved nor disapproved the contents of this press release.
CSE既沒有批准也沒有反對本新聞稿的內容。
譯文內容由第三人軟體翻譯。